Antitubercular Drug induced Hepatitis: An Adverse Drug Reaction
Aisha Begum1★, Uzma Parveen1, Safura Sultana1, Nausheen Fatima1, Mohd Fareedullah1, Zareenunnisa Z1★ Corresponding author
- 1Department of Pharmacy Practice, Deccan School of Pharmacy, Hyderabad, Telangana, INDIA.
CORRESPONDENCE
Aisha Begum
Department of Pharmacy Practice, Deccan School of Pharmacy, Hyderabad, Telangana, INDIA.
Volume 13, Issue 3 · pp. 280–282 · PUBLISHED · DOI: 10.5530/ijopp.13.3.47
ABSTRACT
Antitubercular drugs are the first line agents for the management of tuberculosis. Drug induced hepatotoxicity is an unexceptional adverse effect mostly caused by antitubercular drugs leading to cessation of therapy. The keystone for the treatment of tuberculosis is a 6-month regimen consisting of drugs such as Isoniazid, rifampicin, pyrazinamide and ethambutol. Although Antitubercular drugs are only option for the treatment for pulmonary TB, Hepatotoxicity is one of the most detrimental adverse events leading to interruption of treatment thereby causing drug resistance. In this case the patient was recently diagnosed with pulmonary tuberculosis one month ago, consequently developed hepatotoxicity due to use of anti-tuberculosis drugs. Naranjo Adverse Drug Reaction Probability Scale was used to assess the adverse Drug effect and the score was found to be probable thereby indicating that Anti TB drugs cause hepatitis.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Begum, A., Parveen, U., Sultana, S., Fatima, N., Fareedullah, M., & Z, Z. (). Antitubercular Drug induced Hepatitis: An Adverse Drug Reaction. Indian Journal of Pharmacy Practice, 13(3), 280–282. https://doi.org/10.5530/ijopp.13.3.47